Needham & Company
View Older Stories
-
Genocea to Present at the 20th Annual Needham Virtual Healthcare Conference
-
Genocea to Present at the 20th Annual Needham Virtual Healthcare Conference
-
Genocea Biosciences (GNCA) PT Lowered to $7 at Needham & Company
-
Genocea to Present Virtually at the 19th Annual Needham Healthcare Conference
-
Genocea to Present Virtually at the 19th Annual Needham Healthcare Conference
-
Genocea Biosciences (GNCA) PT Lowered to $10 at Needham & Company
-
Genocea Biosciences (GNCA) Prices 10.5M Share Offering at $3.50/Sh
-
Genocea Announces Pricing of $36,750,000 Public Offering of Common Stock
-
Genocea Announces Pricing of $36,750,000 Public Offering of Common Stock
-
Genocea Biosciences (GNCA) Announces Proposed 10M Share Common Offering
-
Genocea Announces Proposed Public Offering of Common Stock
-
Genocea Announces Proposed Public Offering of Common Stock
-
Genocea to Present at 18th Annual Needham Healthcare Conference
-
Genocea to Present at 18th Annual Needham Healthcare Conference
-
Genocea Biosciences (GNCA) PT Lowered to $2 at Needham & Company
-
Pre-Open Movers 03/06: (AMDA) (CLBS) (GNCA) Higher; (GLYC) (FRPT) (ASNA) Lower (more...)
-
Genocea to Present at Two March Investor Conferences
-
Genocea Reports Fourth Quarter and Full-Year 2017 Financial Results
-
Needham & Company Transfers, Upgrades Genocea Biosciences (GNCA) to Buy
-
Genocea Biosciences (GNCA) Prices $55M Concurrent Public Offerings
-
Genocea Biosciences, Inc. Announces Pricing of $55 Million Concurrent Public Offerings
-
Genocea Biosciences (GNCA) Announces Public Offerings of Common Stock, Class A Warrants, Series A Convertible Preferred Stock and Class A Warrants
-
Genocea Biosciences, Inc. Announces Proposed Concurrent Public Offerings of Common Stock and Class A Warrants and Series A Convertible Preferred Stock and Class A Warrants
-
UPDATE: Needham & Company Downgrades Genocea Biosciences (GNCA) to Hold
-
Pre-Open Movers 07/25: (BKS) (COT) (CAT) Higher; (STX) (NVAX) (GOOGL) Lower (more...)
-
Needham & Company Upgrades Genocea Biosciences (GNCA) to Buy
-
Genocea to Present at the 16th Annual Needham Healthcare Conference
-
Needham & Company Downgrades Genocea Biosciences (GNCA) to Hold
-
Genocea Reports Fourth Quarter and Year-End 2016 Financial Results
-
Genocea to Present at the 15th Annual Needham Healthcare Conference
-
Unusual 11 Mid-Day Movers 4/1: (SKYS) (CSII) (AKTX) Higher; (ROVI) (UPL) (AKER) Lower
-
Pre-Open Stock Movers 04/01: (CSII) (VJET) (TSLA) Higher; (BBRY) (SUNE) (GNCA) Lower (more...)
-
Genocea Biosciences (GNCA) PT Lowered to $15 at Needham & Company
-
Genocea Biosciences, Inc. Announces Closing of $50 Million Public Offering of Common Stock
-
Genocea Biosciences (GNCA) 3.85M Common Stock Offering Prices at $13/Share
-
Genocea Biosciences, Inc. Announces Pricing of $50 Million Public Offering
-
Genocea Biosciences, Inc. Commences Public Offering of Common Stock
-
Genocea to Present at the 14th Annual Needham & Co. Healthcare Conference
-
Genocea Biosciences, Inc. Announces Closing of $51.7 Million Public Offering of Common Stock and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Genocea Biosciences (GNCA) Prices 5.45M Common Share Offering at $8.25/Share
-
Genocea Biosciences, Inc. Announces Pricing of $45 Million Public Offering
-
Genocea Biosciences (GNCA) Plans Common Stock Offering
-
Genocea Biosciences, Inc. Commences Public Offering of Common Stock
-
Genocea Biosciences (GNCA) Begins 3.4M Common Stock Offering
-
Needham & Company Starts Genocea Biosciences (GNCA) at Buy
-
Genocea Biosciences (GNCA) IPO Opens Modeslty Lower after Weak Pricing
-
Genocea Biosciences (GNCA) Files $75M IPO

